Whitfield Roy A

Avg. Two Year Performance

(8%) Avg. Purchase Return
(4%) Compound
(80%) Avg. Sale Return
(34%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return11%52%222%146%(8%)
Purchase Success Rate1 of 22 of 21 of 21 of 21 of 2
Average Sale Return(1%)(7%)(11%)(24%)(80%)
Sale Success Rate14 of 3519 of 3518 of 3513 of 3514 of 35

Nektar Therapeutics

Drugs » Drug Delivery

Director:

Holdings: 287.75K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Incyte Corp

Drugs » Biotechnology

Director:

Holdings: 666.08K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Illumina Inc.

Drugs » Biotechnology

Director:

Holdings: 2.85K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--